The Cancer Letter 12.09.16 The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute announced a collaboration focused on neoantigens Read
FiercePharma 12.06.16 Parker Institute, Cancer Research Institute team up on neoantigen-based cancer vaccines Read
TechCrunch 12.01.16 Sean Parker is partnering with the Cancer Research Institute to find a cancer vaccine Read
San Francisco Business Times 12.01.16 Sean Parker’s big push to hack cancer takes aim at tumor ‘tags’ Read
FierceBiotech 12.01.16 Sean Parker’s I/O group teams up with CRI for cancer neoantigens R&D deal Read
The CenterWatch Weekly 11.28.16 Parker Institute’s IRB Reliance Agreement signals a new phase in the trend toward consolidation Read
ASCO Post 11.25.16 The Emergence of Philanthropy to Fund High-Risk, High-Reward Cancer Research A Conversation With Jeffrey Bluestone, PhD Read